BASEL, Switzerland, May 20, 2021 /PRNewswire/ -- MindMed (Nasdaq: MNMD) (NEO: MMED) (DE: MMQ), a leading clinical stage psychedelic medicine company, announced today the approval by the local Swiss ...

Over the past two decades, researchers have published study after study evaluating the therapeutic potential of psychedelics like psilocybin and LSD. The research is so promising that despite being ...

Lysergic acid diethylamide (LSD), psilocybin (the psychoactive compound in “magic mushrooms”) and mescaline are three of the most widely studied classic psychedelics. Each has a long history of ...

There’s something about mescaline. Prehistoric desert dwellers of the American Southwest and Mexico figured as much out when they figured out that eating peyote — the small, spineless cactus dotting ...

Mescaline also binds to the 5-HT2A receptor with lower potency and higher activity compared to LSD. The present study will also explore the mechanism of action of mescaline in humans and specifically ...

Like many a researcher before him (including the late great Havelock Ellis), British Psychiatrist John Smythies was fascinated by the extraordinary visions he had after taking mescaline, an alkaloid ...

Mescaline: A Global History of the First Psychedelic. By Mike Jay.Yale University Press; 304 pages; $26 and £18.99. MESCALINE IS THE drug that launched the modern fascination with hallucinogens. It is ...

On a placid June morning two years ago, I embarked on a creative and spiritual voyage into the abyss that began by swallowing a potent cup of liquid LSD. The initial effects were almost identical to ...

BASEL, Switzerland, May 20, 2021 /CNW/ -- MindMed (Nasdaq: MNMD) (NEO: MMED) (DE: MMQ), a leading clinical stage psychedelic medicine company, announced today the approval by the local Swiss ethics ...